NO980252L - In vivo diabetes-test - Google Patents

In vivo diabetes-test

Info

Publication number
NO980252L
NO980252L NO980252A NO980252A NO980252L NO 980252 L NO980252 L NO 980252L NO 980252 A NO980252 A NO 980252A NO 980252 A NO980252 A NO 980252A NO 980252 L NO980252 L NO 980252L
Authority
NO
Norway
Prior art keywords
diabetes testing
diagnosis
vivo
agent
mediated diseases
Prior art date
Application number
NO980252A
Other languages
English (en)
Norwegian (no)
Other versions
NO980252D0 (no
Inventor
Josef Endl
Manfred Ganz
Peter Stahl
Rosemarie Kientsch-Engel
Guenther-Gerhard Jung
Paolo Pozzilli
Frederic Donie
Original Assignee
Boehringer Mannheim Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Mannheim Gmbh filed Critical Boehringer Mannheim Gmbh
Publication of NO980252D0 publication Critical patent/NO980252D0/no
Publication of NO980252L publication Critical patent/NO980252L/no

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/0004—Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions
    • A61K49/0006—Skin tests, e.g. intradermal testing, test strips, delayed hypersensitivity
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/88—Lyases (4.)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/04—Endocrine or metabolic disorders
    • G01N2800/042—Disorders of carbohydrate metabolism, e.g. diabetes, glucose metabolism

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Zoology (AREA)
  • Endocrinology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Hospice & Palliative Care (AREA)
  • General Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Rehabilitation Therapy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dermatology (AREA)
  • Diabetes (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
NO980252A 1995-07-20 1998-01-20 In vivo diabetes-test NO980252L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19526561A DE19526561A1 (de) 1995-07-20 1995-07-20 In-vivo-Diabetes-Test
PCT/EP1996/003192 WO1997003704A2 (de) 1995-07-20 1996-07-19 In-vivo-diabetes-test

Publications (2)

Publication Number Publication Date
NO980252D0 NO980252D0 (no) 1998-01-20
NO980252L true NO980252L (no) 1998-01-20

Family

ID=7767366

Family Applications (1)

Application Number Title Priority Date Filing Date
NO980252A NO980252L (no) 1995-07-20 1998-01-20 In vivo diabetes-test

Country Status (10)

Country Link
EP (1) EP0839058A2 (de)
JP (1) JPH11509538A (de)
KR (1) KR19990035757A (de)
CN (1) CN1191493A (de)
AU (1) AU6658296A (de)
CA (1) CA2225145A1 (de)
DE (1) DE19526561A1 (de)
IL (1) IL122816A0 (de)
NO (1) NO980252L (de)
WO (1) WO1997003704A2 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997036618A1 (fr) * 1996-04-01 1997-10-09 Chugai Seiyaku Kabushiki Kaisha Composition diagnostique pour maladies s'accompagnant de reactions auto-immunes declenchees par la decarboxylase d'acide 65k-glutamique
US6750201B1 (en) 1997-10-17 2004-06-15 The Trustees Of The University Of Pennsylvania Compositions and methods for promoting internalization and degradation of urokinase-type plasminogen activator
KR100681339B1 (ko) * 2004-12-23 2007-02-15 최성환 연탄보일러

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3626054A (en) * 1967-10-25 1971-12-07 Bard Hamilton Co Inc Lupus erythematosus skin test
US5674978A (en) * 1990-09-21 1997-10-07 The Regents Of The University Of California Peptides derived from glutamic acid decarboxylase
CA2140591A1 (en) * 1994-01-20 1995-07-21 Josef Endl Antigen-specific, activated t lymphocytes, detection and use
DE19525784A1 (de) * 1995-07-14 1997-01-16 Boehringer Mannheim Gmbh Autoreaktive Peptide aus der humanen Glutamin-Decarboxylase (GAD)

Also Published As

Publication number Publication date
DE19526561A1 (de) 1997-01-23
CN1191493A (zh) 1998-08-26
NO980252D0 (no) 1998-01-20
EP0839058A2 (de) 1998-05-06
WO1997003704A3 (de) 1997-06-05
CA2225145A1 (en) 1997-02-06
WO1997003704A2 (de) 1997-02-06
AU6658296A (en) 1997-02-18
IL122816A0 (en) 1998-08-16
KR19990035757A (ko) 1999-05-25
JPH11509538A (ja) 1999-08-24

Similar Documents

Publication Publication Date Title
HUP0301729A2 (hu) Gyógyszer szívelégtelenség megelżzésére és kezelésére
TW286360B (de)
HUP0101994A2 (hu) Eszköz valamely gyógyszervegyület vérparaméterekre gyakorolt hatásainak in vivo meghatározására, valamint alkalmazása
PT1131039E (pt) Utilizacao de uma substancia que se liga ao receptor periferico das benzodiazepinas no tratamento de stresses cutaneos
BR0103256A (pt) Utilização de substâncias bioquìmicas para uma composição para a prevenção e tratamento de condições de saúde causadas por constrição de células de músculo liso em órgãos do corpo humano
DE69404460D1 (de) Zell-test für alzheimersche krankheit
ES2189961T3 (es) Un ensayo de diagnostico para la esquizofrenia que emplea niacina.
NO980252L (no) In vivo diabetes-test
DE69841804D1 (de) Diagnoseverfahren
DK0795130T3 (da) Diagnostisk metode ved inflammatoriske tilstande i tarmene
ATE213082T1 (de) Notruf- oder diagnosegerät
Cairns et al. Computerized version of the time-insensitive predictive instrument. Use of the Q wave, ST-segment, T wave, and patient history in the diagnosis of acute myocardial infarction by the computerized ECG
HUP0200475A2 (hu) Perfluor-alkil-amidok, azok előállítása, és diagnosztikai alkalmazása
DK0568554T3 (da) Fremgangsmåde til påvisning af anti-RNA-antistoffer
HUP0001167A2 (hu) Fertőzés és gyulladás képi megjelenítésére szolgáló radiokészítmények
MD121B1 (ro) Procedeu de obtinere a derivatilor tienopiranului
ATE320272T1 (de) Verwendung von kontrastmitteln zur herstellung eines diagnostischen mittels für die darm- lumenbildgebung
ATE222762T1 (de) 4-hydroxycoumarin-3-carboxamide für die behandlung von nicht-insulin-abhängigen diabetes mellitus
Rosati et al. Clinical validity of the elbow flexion test for the diagnosis of ulnar nerve compression at the cubital tunnel
Zito et al. Effects of antihypertensive therapy with lacidipine on ambulatory blood pressure in the elderly.
DE69405284D1 (de) Manschette für Blutdruckmesser
Wide Mercury hazards arising from the repair of sphygmomanometers.
FR2716104B1 (fr) Protection microbiologique à usage unique de la membrane du stéthoscope médical.
Litt Ephebiatric Lingo
KR970020057A (ko) 혈압계 시계

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application